References
- Chien YW. (1983). Comparative controlled skin permeation of nitroglycerin from marketed transdermal delivery systems. J Pharm Sci, 72:968–70.
- Loftsson T, Gildersleeve N, Border N. (1987). The effect of vehicle additives on the transdermal delivery of nitroglycerin. Pharm Res, 4:436–44.
- Corbo M, Liu JC, Chien YW. (1990). Bioavailability of propranolol following oral & transdermal administration in rabbits. J Pharm Sci, 79:584–7.
- Aqil M, Sultana Y, Ali A. (2003). Matrix type transdermal drug delivery systems of metoprolol tartrate: In vitro characterization. Acta Pharm, 53:119–25.
- Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev, 56:603–18.
- Bohme K. (2002). Buprenorphine in a transdermal therapeutic system—A new option. Clin Rheumatol, 21(1):S13–6.
- Anon. (1959). Dewaxed damar—A review. Paint Oil Colour J, 11:215–8.
- Anon. (1973). Damar FPRI Technical Note No. 136. Laguna, the Philippines: Forest Products Research and Industries Development Commission, 3.
- Mundada AS, Satturwar PM, Fulzele SV, Joshi SB, Dorle AK. (2009). Damar Batu: Novel film forming polymer for drug delivery. Drug Deliv Tech, in press.
- Kerins DM, Robertson RM, Robertson D. (2001). Drugs used for the treatment of myocardial ischemia. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman Gilman's: The pharmacological basis of therapeutics. 10th ed. Columbus (OH): McGraw Hill Comp., 856–9.
- Raynolds JEF. (1996). Martindale: The extra pharmacopoeia. 31st ed. London: Royal Pharmaceutical Society, 857.
- Rao RP, Diwan PV. (1998). Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev Ind Pharm, 24:327–36.
- Gupta R, Mukherjee B. (2003). Development and in vitro evaluation of diltiazem hydrochloride transdermal patches on povidone-ethylcellulose matrices. Drug Dev Ind Pharm, 29:1–7.
- Jain SK, Chaurasia MK, Sabitha M, Jain R, Jain AK, Ashawat M, . (2003). Development and characterization of transdermal drug delivery systems for diltiazem hydrochloride. Drug Deliv, 10:169–77.
- Mundada AS, Shrikhande BK. (2006). Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride. Drug Dev Ind Pharm, 32:443–8.
- Seth AK, Agrawal GP, Saini TR. (1985). Evaluation of free films. Ind Drugs, 23:45–7.
- ASTM Standards, D882-95a. (1995). Tensile properties of thin plastic sheeting. West Conshohocken (PA): American Society for Testing and Materials.
- Ubaidulla U, Reddy MVS, Ruckmani K, Ahmed FJ, Khar RK. (2007). Transdermal therapeutic system of carvedilol: Effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech, 8(1):E1–8.
- Mazzo DJ, Obetz CL, Shuster J. (1994). In: Brittain HG, ed. Analytical profiles of drug substances and excipients, vol. 23. San Diego, CA: Academic Press Inc., 53.
- US Pharmacopeia XXIII. (1995). US Pharmacopoeial convention. Rockville, MD, pp. 1796.
- Berner B, Mazzenga GC, Otte JH, Steffens RJ, Juang RH, Ebert CD. (1989). Ethanol: water mutually enhanced transdermal therapeutic system II: Skin permeation of ethanol and nitroglycerine. J Pharm Sci, 78:402–7.
- Chien YW, Valia KH. (1984). Development of a dynamic skin permeation system for long term studies. Drug Dev Ind Pharm, 10:575–99.
- Sarpotdar PP, Gaskill JL, Giannini RP. (1986). Effect of polyethylene glycol 400 on the penetration of drugs through human cadaver skin in vitro. J Pharm Sci, 75:26–8.
- Bonina FP, Carellii V, Cols GD, Montenegro L, Nannipieri E. (1993). Vehicle effects on in vitro skin permeation and stratum corneum affinity for model drugs caffeine and testosterone. Int J Pharm, 100:41–7.
- Mutalik S, Udupa N. (2004). Glibenclamide transdermal patches: Physicochemical, pharmacodynamic, and pharmacokinetic evaluations. J Pharm Sci, 93:1577–94.
- Draize JH, Woodward GS, Calvery HO. (1944). Method for the study of irritation and toxicity of substances applied topically to the skin and mucus membrane. J Pharmacol Exp Ther, 82:377–90.
- Aqil M, Ali A. (2002). Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: In vitro characterization. Eur J Pharm Biopharm, 54:161–4.
- Lopez CR, Bodmeier R. (1996). Mechanical and water vapor transmission properties of polysaccharide films. Drug Dev Ind Pharm, 22:1201–9.
- Sood A, Panchagnula R. (1999). Role of dissolution studies in controlled release drug delivery system. STP Pharm Sci, 9:157–68.
- Bodmeier R, Paeratakul O. (1990). Theophylline tablets coated with aqueous latexes containing dispersed pore formers. J Pharm Sci, 79:32.
- Rao RP, Ramakrishna S, Diwan PV. (2000). Drug release kinetics from polymeric films containing propranolol hydrochloride for transdermal use. Pharm Dev Tech, 5:465–72.
- Katayose S, Kataoka K. (1997). Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(l-lysine) block copolymer. Bioconjug Chem, 8:702–7.
- Chien YW. (1987). Development of transdermal drug delivery system. Drug Dev Ind Pharm, 13:589–651.
- Chang RK, Peng Y, Shukla AJ. (2006). Polymethacrylates. In: Rowe RC, Sheskey PJ, Owen SC, eds. Handbook of phramaceutical excipients. 5th ed. London: Pharmaceutical Press, 553–60.